SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: Captain Jack who wrote (1240)1/3/1999 10:11:00 PM
From: billkirn  Read Replies (1) | Respond to of 1510
 
Quite frankly, when Peter Johnson ceo of agph spoke about IMNR and I got the impression he felt it was a long shot the Remune would make it. He indicated it was AGPH's responsibility, as the leading aids drug mfg., to encourage Remune, with the hope it would work for the long term care of HIV patients.
I wouldn't bet the farm on this product making a real impact.
Bill